Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease

Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease

Abstract Background Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge for providers caring for patients with cardiometabolic diseases. NAs and DDIs are both ubiquitous and often overlooked. We studied a novel ch...

Full description

Bibliographic Details
Main Authors: John W Peabody, Divya Ganesan, Czarlota Valdenor, David Paculdo, Joshua Schrecker, Christopher Westerfield, Rebecca Heltsley
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Primary Care
Subjects:
Adverse drug reactions
Cardiometabolic diseases
Disease progression
Drug-drug interactions
Medication nonadherence
Polypharmacy
Online Access:https://doi.org/10.1186/s12875-023-02042-4

Internet

https://doi.org/10.1186/s12875-023-02042-4

Similar Items